Announced Thu, 6 Nov · 15:10 IST
Beta Drugs Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
Results View source PDF
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Beta Drugs Limited has submitted its financial results for the quarter and half-year ended September 30, 2025, to the NSE. The headline announcement indicates compliance with listing requirements for periodic financial disclosure. No specific revenue, profit, or margin figures are disclosed in this filing excerpt, so the actual performance numbers would need to be reviewed from the detailed results document.
Likely market impact
Routine regulatory filing; investors should review the detailed results for revenue, profit, and margin trends before drawing any conclusions about the stock.